Want to see IN:SHK full AI Analyst Report?
SHK Stock Chart & Stats
₹181.95
-₹0.75(-0.33%)
At close: 4:00 PM EST
₹181.95
-₹0.75(-0.33%)
Day’s Range― - ―
52-Week Range₹111.70 - ₹275.20
Previous CloseN/A
Volume527.21K
Average Volume (3M)19.27K
Market Cap
₹19.79B
Enterprise Value₹25.15K
Total Cash (Recent Filing)₹672.00M
Total Debt (Recent Filing)₹10.29B
Price to Earnings (P/E)27.8
Beta1.74
Next Earnings
Jul 28, 2026Next Dividend Ex-DateN/A
Dividend Yield1.44%
Share Statistics
EPS (TTM)5.00
Shares Outstanding138,420,800
10 Day Avg. Volume25,737
30 Day Avg. Volume19,269
Financial Highlights & Ratios
PEG Ratio-3.85
Price to Book (P/B)1.14
Price to Sales (P/S)0.66
P/FCF Ratio293.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.8
Revenue Forecast (FY)₹25.92B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent top-line expansion and the reported step-up from 2021–2026 indicate durable demand for SHK's fragrance and flavour solutions. Sustained revenue growth supports scale economics, customer access, and the ability to invest in R&D and manufacturing capacity over the next 2–6 months and beyond.
B2B Recurring Model & Formulation ExpertiseThe company's business model relies on formulation, application support, and repeat B2B orders, creating customer stickiness and switching costs. Technical formulation services and co-development with FMCG clients produce steady, contract-driven revenue that is resilient to short-term retail swings.
Serviceable Balance Sheet BaseA moderate leverage profile combined with an expanded equity base gives the company room to service obligations and absorb operational variability. This financial headroom supports continued investment in working capital and production capacity, maintaining supply reliability to clients over the medium term.
Bears Say
Margin DeteriorationSharply lower gross and operating margins materially reduce intrinsic earning power and reinvestment capacity. If margin pressure reflects structural input-cost, mix, or pricing issues, profitability may remain depressed, limiting ability to restore returns and finance growth without cost or pricing remediation.
Weak Free Cash Flow ConversionVolatile and weak FCF conversion signals that reported profits are not reliably converting to spendable cash. Elevated working-capital needs or investment outlays can constrain funding for capex, debt reduction, dividends, or strategic initiatives, raising financing risk over the coming months.
Rising Debt And Cooling ReturnsIncreasing leverage alongside a steep ROE decline indicates the company is earning less on a larger capital base, eroding shareholder returns. Persistent lower returns reduce financial flexibility and increase sensitivity to interest and market shocks, amplifying medium-term operational risk.
S H Kelkar and Company Ltd News
SHK FAQ
What was S H Kelkar and Company Ltd’s price range in the past 12 months?
S H Kelkar and Company Ltd lowest stock price was ₹111.70 and its highest was ₹275.20 in the past 12 months.
What is S H Kelkar and Company Ltd’s market cap?
S H Kelkar and Company Ltd’s market cap is ₹19.79B.
When is S H Kelkar and Company Ltd’s upcoming earnings report date?
S H Kelkar and Company Ltd’s upcoming earnings report date is Jul 28, 2026 which is in 5 days.
How were S H Kelkar and Company Ltd’s earnings last quarter?
S H Kelkar and Company Ltd released its earnings results on May 15, 2026. The company reported ₹0.1 earnings per share for the quarter, missing the consensus estimate of ₹1.6 by -₹1.5.
Is S H Kelkar and Company Ltd overvalued?
According to Wall Street analysts S H Kelkar and Company Ltd’s price is currently Overvalued.
Does S H Kelkar and Company Ltd pay dividends?
S H Kelkar and Company Ltd pays a Annually dividend of ₹1 which represents an annual dividend yield of 1.44%. See more information on S H Kelkar and Company Ltd dividends here
What is S H Kelkar and Company Ltd’s EPS estimate?
S H Kelkar and Company Ltd’s EPS estimate is 1.
How many shares outstanding does S H Kelkar and Company Ltd have?
S H Kelkar and Company Ltd has 138,420,800 shares outstanding.
What happened to S H Kelkar and Company Ltd’s price movement after its last earnings report?
S H Kelkar and Company Ltd reported an EPS of ₹0.1 in its last earnings report, missing expectations of ₹1.6. Following the earnings report the stock price went down -4.764%.
Which hedge fund is a major shareholder of S H Kelkar and Company Ltd?
Currently, no hedge funds are holding shares in IN:SHK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
S H Kelkar and Company Ltd
S H Kelkar and Company Limited, in conjunction with its subsidiary entities, functions as a principal producer and purveyor of aromatic compounds, flavorings, and various aroma ingredients, serving markets primarily in India and through exports. The company's fragrance offerings are incorporated into a broad spectrum of products, including those for personal hygiene, hair care, skin treatment, cosmetics, fabric conditioning, general household use, and high-end perfumes. Concurrently, its flavors are vital components in items such as dairy products, beverages, confectionery, baked goods, pharmaceuticals, nutraceuticals, and savory dishes. S H Kelkar markets its product lines through distinct brands like SHK, Cobra, and Keva, catering to a diverse customer base that spans major domestic and international Fast-Moving Consumer Goods (FMCG) corporations, alongside specialized blenders and manufacturers within the fragrance and flavor industries. The firm, established in 1914, is headquartered in Mumbai, India.
Technical Analysis
AVT Natural Products Limited
―
Camlin Fine Sciences Limited
―
Oriental Aromatics Ltd.
―
Privi Speciality Chemicals Limited
―
Rossari Biotech Ltd
―